1210971

Boehringer Ingelheim RCV GmbH & Co KG — FEI 3003433722

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 2, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vienna (Austria)

Additional Details

Mutual Recognition Agreement (MRA)